Texas judge transferred FDA mifepristone lawsuit to Missouri. Supreme Court dismissed antiabortion activists' lawsuit, noting doctors didn't show harm from mifepristone regulations. States claim FDA policy endangers women and violates anti-abortion laws. States seek to limit mifepristone access to seven weeks and require in-person visits for prescriptions